Top

International Journal of Colorectal Disease

Published in:

01-01-2012 | Original Article

Quality of surgical care, local recurrence, and survival in patients with low- and midrectal cancers following multimodal therapy

Authors: Ilmo Kellokumpu, Jaana Vironen, Matti Kairaluoma, Ismo Jantunen, Hannu Kautiainen, Kyösti Nuorva

Published in: International Journal of Colorectal Disease | Issue 1/2012

Abstract

Purpose

To assess the quality of surgical care and outcome following multimodal treatment for low- and midrectal cancers, focusing on differences between low anterior and abdominoperineal resections.

Methods

From 1999 to 2007, 179 patients underwent low anterior resection (LAR), abdominoperineal resection (APR), or proctocolectomy for low- or midrectal cancers. Preoperative (chemo)radiotherapy was given according to local guidelines and adjuvant postoperative chemotherapy in stage III disease. Outcome together with clinical and histopathological data were analyzed in relation to the type of surgery performed.

Results

The postoperative mortality was 2.2%; morbidity, 39.6%; reoperation rate, 8.4%; and readmission rate, 16.0%. Involved circumferential resection margin (CRM ≤ 1 mm) rate was 4.5% (APR 9.1% vs. LAR 2.6%, p = 0.046). Intraoperative bowel perforation occurred in 5.5% of APRs. Anastomotic leak rate was 15.3%. The 5-year overall survival of the 179 patients was 68.5 %; disease-specific survival, 82.2%; and local recurrence rate, 6.3%. The overall, disease-specific, and disease-free survival rates in the 162 patients treated for cure were 73.1%, 84.6%, and 78.3%, and local recurrence rate was 4.4% with no significant differences between LAR and APR. CRM was the only independent predictor of local recurrence and CRM, tumor stage, and level independent predictors of disease-free survival.

Conclusions

Quality of surgical care was in line with the current international standards. CRM was an independent predictor for local recurrence and CRM, tumor stage, and level independent prognostic factors for disease-free survival. Neither the type of surgery (LAR vs. APR) nor the surgical approach (laparoscopic vs. open) influenced the oncologic outcome.

Dahlberg M, Glimelius B, Pahlman L (1999) Changing strategy for rectal cancer is associated with improved outcome. Br J Surg 86:379–384PubMedCrossRef

Peeters KC, Marijnen CA, Nagtegaal ID, Kranenbarg EK, Putter H, Wiggers T, Rutten H, Pahlman L, Glimelius B, Leer JW, van de Velde CJ, Dutch Colorectal Cancer Group (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693–701PubMedCrossRef

Sauer R, Becker H, Hohenberger W, Rodel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740PubMedCrossRef

Kressner M, Bohe M, Cedermark B, Dahlberg M, Damber L, Lindmark G, Ojerskog B, Sjodahl R, Johansson R, Pahlman L (2009) The impact of hospital volume on surgical outcome in patients with rectal cancer. Dis Colon Rectum 52:1542–1549PubMedCrossRef

den Dulk M, Putter H, Collette L, Marijnen CA, Folkesson J, Bosset JF, Rodel C, Bujko K, Pahlman L, van de Velde CJ (2009) The abdominoperineal resection itself is associated with an adverse outcome: the European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer 45:1175–1183CrossRef

den Dulk M, Marijnen CA, Putter H, Rutten HJ, Beets GL, Wiggers T, Nagtegaal ID, van de Velde CJ (2007) Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg 246:83–90CrossRef

Marr R, Birbeck K, Garvican J, Macklin CP, Tiffin NJ, Parsons WJ, Dixon MF, Mapstone NP, Sebag-Montefiore D, Scott N, Johnston D, Sagar P, Finan P, Quirke P (2005) The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg 242:74–82PubMedCrossRef

Anderin C, Martling A, Hellborg H, Holm T (2010) A population-based study on outcome in relation to the type of resection in low rectal cancer. Dis Colon Rectum 53:753–760PubMedCrossRef

Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P, Dutch Colorectal Cancer Group, Pathology Review Committee (2005) Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 23:9257–9264PubMedCrossRef

10.

Wibe A, Syse A, Andersen E, Tretli S, Myrvold HE, Soreide O, Group Norwegian Rectal Cancer (2004) Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum 47:48–58PubMedCrossRef

11.

Shihab OC, Brown G, Daniels IR, Heald RJ, Quirke P, Moran BJ (2010) Patients with low rectal cancer treated by abdominoperineal excision have worse tumors and higher involved margin rates compared with patients treated by anterior resection. Dis Colon Rectum 53:53–56PubMedCrossRef

12.

Salerno G, Chandler I, Wotherspoon A, Thomas K, Moran B, Brown G (2008) Sites of surgical wasting in the abdominoperineal specimen. Br J Surg 95:1147–1154PubMedCrossRef

13.

MacFarlane JK, Ryall RD, Heald RJ (1993) Mesorectal excision for rectal cancer. Lancet 341:457–460PubMedCrossRef

14.

Rahbari NN, Weitz J, Hohenberger W, Heald RJ, Moran B, Ulrich A, Holm T, Wong WD, Tiret E, Moriya Y, Laurberg S, den Dulk M, van de Velde C, Buchler MW (2010) Definition and grading of anastomotic leakage following anterior resection of the rectum: a proposal by the international study group of rectal cancer. Surgery 147:339–351PubMedCrossRef

15.

Sobin LH, Wittekind C (2002) TNM classification of malignant tumours, 6th edn. Wiley & Sons, New Jersey

16.

Nagtegaal ID, van de Velde CJ, van der Worp E, Kapiteijn E, Quirke P, van Krieken JH, Cooperative Clinical Investigators of the Dutch Colorectal Cancer Group (2002) Macroscopic evaluation of rectal cancer resection specimen: clinical significance of the pathologist in quality control. J Clin Oncol 20:1729–1734PubMedCrossRef

17.

Dent OF, Haboubi N, Chapuis PH, Chan C, Lin BP, Wong SK, Bokey EL (2007) Assessing the evidence for an association between circumferential tumour clearance and local recurrence after resection of rectal cancer. Colorectal Dis 9:112–121. doi:discussion121-122 PubMedCrossRef

18.

Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19–23PubMedCrossRef

19.

Pahlman L, Gunnarsson U, Karlbom U (2005) The influence on treatment outcome of structuring rectal cancer care. Eur J Surg Oncol 31:645–649PubMedCrossRef

20.

Nagtegaal ID, Marijnen CA, Kranenbarg EK, van de Velde CJ, van Krieken JH, Committee PR, Investigators CC (2002) Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 26:350–357PubMedCrossRef

21.

Bernstein TE, Endreseth BH, Romundstad P, Wibe A, Norwegian Colorectal Cancer Group (2009) Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg 96:1348–1357PubMedCrossRef

22.

Birbeck KF, Macklin CP, Tiffin NJ, Parsons W, Dixon MF, Mapstone NP, Abbott CR, Scott N, Finan PJ, Johnston D, Quirke P (2002) Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235:449–457PubMedCrossRef

23.

Merkel S, Klossek D, Gohl J, Papadopoulos T, Hohenberger W, Hermanek P (2009) Quality management in rectal carcinoma: what is feasible? Int J Colorectal Dis 24:931–942PubMedCrossRef

24.

den Dulk M, Collette L, van de Velde CJ, Marijnen CA, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bosset JF, Radiation Oncology Group EORTC (2007) Quality of surgery in T3-4 rectal cancer: involvement of circumferential resection margin not influenced by preoperative treatment. Results from EORTC trial 22921. Eur J Cancer 43:1821–1828CrossRef

25.

Marijnen CA, van de Velde CJ (2001) Preoperative radiotherapy for rectal cancer. Br J Surg 88:1556–1557PubMedCrossRef

26.

Elferink MA, van Steenbergen LN, Krijnen P, Lemmens VE, Rutten HJ, Marijnen CA, Nagtegaal ID, Karim-Kos HE, de Vries E, Siesling S, Working Group Output of The Netherlands Cancer Registry (2010) Marked improvements in survival of patients with rectal cancer in The Netherlands following changes in therapy, 1989–2006. Eur J Cancer 46:1421–1429PubMedCrossRef

27.

Marijnen CA, Nagtegaal ID, Kapiteijn E, Kranenbarg EK, Noordijk EM, van Krieken JH, van de Velde CJ, Leer JW, Cooperative investigators of the Dutch Colerectal Cancer Group (2003) Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55:1311–1320PubMedCrossRef

28.

Holm T, Ljung A, Haggmark T, Jurell G, Lagergren J (2007) Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 94:232–238PubMedCrossRef

29.

Balch GC, De Meo A, Guillem JG (2006) Modern management of rectal cancer: a 2006 update. World J Gastroenterol 12:3186–3195PubMed

30.

Ignjatovic D, Bergamaschi R (2006) Rectal cancer: from outcomes of care to process of care. Scand J Gastroenterol 41:636–639PubMedCrossRef

31.

van Gijn W, Wouters MW, Peeters KC, van de Velde CJ (2009) Nationwide outcome registrations to improve quality of care in rectal surgery. An initiative of the European Society of Surgical Oncology. J Surg Oncol 99:491–496PubMedCrossRef

32.

Pachler J, Wille-Jorgensen P (2005) Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev (2):CD004323

33.

Vironen JH, Kairaluoma M, Aalto AM, Kellokumpu IH (2006) Impact of functional results on quality of life after rectal cancer surgery. Dis Colon Rectum 49:568–578PubMedCrossRef

34.

Jayne DG, Thorpe HC, Copeland J, Quirke P, Brown JM, Guillou PJ (2010) Five-year follow-up of the medical research council CLASICC trial of laparoscopically assisted versus open surgery for colorectal cancer. Br J Surg 97:1638–1645PubMedCrossRef

Title: Quality of surgical care, local recurrence, and survival in patients with low- and midrectal cancers following multimodal therapy
Authors: Ilmo Kellokumpu
Jaana Vironen
Matti Kairaluoma
Ismo Jantunen
Hannu Kautiainen
Kyösti Nuorva
Publication date: 01-01-2012
Publisher: Springer-Verlag
Published in: International Journal of Colorectal Disease / Issue 1/2012
Print ISSN: 0179-1958
Electronic ISSN: 1432-1262
DOI: https://doi.org/10.1007/s00384-011-1322-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Quality of surgical care, local recurrence, and survival in patients with low- and midrectal cancers following multimodal therapy

Abstract

Purpose

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2012

Fulminant gangrenous ischemic colitis: is it the solely severe type of ischemic colitis?

Mentored trainees obtain comparable operative results to experts in complex laparoscopic colorectal surgery

Intra-abdominal dilation of artificial bowel sphincter pressure-regulating balloon: a case report

Extraperitoneal vs. intraperitoneal route for permanent colostomy: a meta-analysis of 1,071 patients

Blood albumin level in cases with colorectal cancer

Common bile duct obstruction by intraluminal colorectal metastasis without evidence of liver or intraabdominal nodal metastasis